Article Listing - FDA asks for more data on Orphan's Xyrem

HAFSLUND NYCOMED 46% OPERATING PROFIT JUMP

17 February 1992

Norwegian company Haflsund Nycomed reported a massive 46% rise in total operating profits for 1991, reaching 1.58 billion Norwegian kroner...

US OTC DRUGMAKERS A TAKEOVER TARGET

17 February 1992

The value of over-the-counter medicine franchises will continue to rise and as a result smaller OTC drugmakers (such as Carter...

MOROCCO BANS GLAFENINE

10 February 1992

Morocco is the latest country to ban marketing of Roussel Uclaf's glafenine-based analgesic products Adalgur, Glifanan and Myantal. A...

SALMON CALCITONIN ASSAY FROM CORTECS

10 February 1992

UK company Cortecs Diag-nostics has developed an enzyme immunoassay for salmon calcitonin which employs an improvement on procedural format with...

H2 BLOCKERS FOR RHINITIS?

10 February 1992

The possibility that histamine H2 receptor blockers may be useful as a treatment for individuals with rhinitis has been raised...

B-MS SCHOOL OF PUBLIC HEALTH

10 February 1992

US concern Bristol-Myers Squibb is to fund its school of public health for a period of five years to the...

GERMAN DRUG CONSUMPTION

10 February 1992

Klaus Stuerzbecher, president of the German federation of pharmacists, the ABDA, has said that a new ABDA study shows that,...

FRENCH HEALTH SPENDING SURPLUS

10 February 1992

The French social security budget is expecting to post a deficit of only 2 billion French francs ($364.3 million), this...

APPROVAL SETBACK FOR US BIOSCIENCE

10 February 1992

The US Food and Drug Administra-tion's Oncologic Drugs Advisory Committee has declined to recommend marketing approval of US Biosci-ence Inc's...

CORTEX IN STROKE TREATMENT JV

10 February 1992

Two US biotechnology companies have agreed to develop potential treatments for stroke and other acute degenerative brain disorders. Cortex Pharmaceuticals...

Showing 94751-94760 of 95316 articles